Sign In
Buy AZN
$181.02
+4.59 (+2.60%)
At Close: Jun 23, 2026
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against AstraZeneca PLC
11:00am, Thursday, 13'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZ
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors are a
AstraZeneca's £2.8bn shot following upgrade
08:02am, Thursday, 13'th Feb 2025
AstraZeneca PLC (LSE:AZN) shares climbed 1.6% in early trading, adding £2.9 billion to the company's market value after UBS upgraded its rating to 'buy' from 'neutral'. The investment bank raised
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against As
NEW YORK , Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class per
Shareholders that Lost Money on AstraZeneca PLC (AZN) Should Contact Levi & Korsinsky about Pending Class Action - AZN
07:00pm, Wednesday, 12'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
Investors who Lost Money on AstraZeneca PLC (AZN) Should Contact Levi & Korsinsky about Pending Class Action - AZN
06:30pm, Wednesday, 12'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZN
06:00pm, Wednesday, 12'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
Shareholders that lost money on AstraZeneca PLC (AZN) should contact The Gross Law Firm about pending Class Action - AZN
12:50pm, Wednesday, 12'th Feb 2025
NEW YORK,, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN).
February 21, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AZN
12:45pm, Wednesday, 12'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
AstraZeneca PLC Is Being Sued For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm
11:00am, Wednesday, 12'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZ
February 21, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AZN
10:30am, Wednesday, 12'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities la
AstraZeneca gets the seal of approval from leading US investment bank - here's why
09:19am, Wednesday, 12'th Feb 2025
Morgan Stanley has initiated coverage of AstraZeneca PLC (LSE:AZN) with an ‘overweight' rating, highlighting the pharmaceutical giant's current share price as a "compelling entry point" ahead of ke
